Literature DB >> 19166313

Two distinct motifs within the p53 transactivation domain bind to the Taz2 domain of p300 and are differentially affected by phosphorylation.

Lisa M Miller Jenkins1, Hiroshi Yamaguchi, Ryo Hayashi, Scott Cherry, Joseph E Tropea, Maria Miller, Alexander Wlodawer, Ettore Appella, Sharlyn J Mazur.   

Abstract

The tumor suppressor p53 functions as a transcriptional activator for many genes, including several key genes involved in cell cycle arrest and apoptosis. Following DNA damage-induced stress, p53 undergoes extensive posttranslational modification, resulting in increased stability and activity. Two critical cofactors for p53-mediated transactivation are the histone acetyltransferase paralogues CREB-binding protein (CBP) and p300. The N-terminal transactivation domain of p53 interacts with several domains of CBP/p300, including the Taz2 domain. Here, we report the effects of specific p53 phosphorylations on its interaction with the Taz2 domain of p300. Using a competitive fluorescence anisotropy assay, we determined that monophosphorylation of p53 at Ser(15) or Thr(18) increased the affinity of p53(1-39) for Taz2, and diphosphorylations at Ser(15) and Ser(37) or Thr(18) and Ser(20) further increased the affinity. In addition, we identified a second binding site for Taz2 within p53 residues 35-59. This second site bound Taz2 with a similar affinity as the first site, but the binding was unaffected by phosphorylation. Thus, p53 posttranslational modification modulates only one of the two binding sites for p300 Taz2. Further investigation of Taz2 binding to p53(1-39) or p53(35-59) by isothermal titration calorimetry indicated that upon complex formation, the change in heat capacity at constant pressure, DeltaC(p), was negative for both sites, suggesting the importance of hydrophobic interactions. However, the more negative value of DeltaC(p) for Taz2 binding to the first (-330 cal/(mol.K)) compared to the second site (-234 cal/(mol.K)) suggests that the importance of nonpolar and polar interactions differs between the two sites.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19166313      PMCID: PMC2848171          DOI: 10.1021/bi801716h

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  51 in total

1.  Interaction between replication protein A and p53 is disrupted after UV damage in a DNA repair-dependent manner.

Authors:  N A Abramova; J Russell; M Botchan; R Li
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

2.  p300/MDM2 complexes participate in MDM2-mediated p53 degradation.

Authors:  S R Grossman; M Perez; A L Kung; M Joseph; C Mansur; Z X Xiao; S Kumar; P M Howley; D M Livingston
Journal:  Mol Cell       Date:  1998-10       Impact factor: 17.970

3.  DNA damage activates p53 through a phosphorylation-acetylation cascade.

Authors:  K Sakaguchi; J E Herrera; S Saito; T Miki; M Bustin; A Vassilev; C W Anderson; E Appella
Journal:  Genes Dev       Date:  1998-09-15       Impact factor: 11.361

4.  Recruitment of p300/CBP in p53-dependent signal pathways.

Authors:  M L Avantaggiati; V Ogryzko; K Gardner; A Giordano; A S Levine; K Kelly
Journal:  Cell       Date:  1997-06-27       Impact factor: 41.582

5.  Two tandem and independent sub-activation domains in the amino terminus of p53 require the adaptor complex for activity.

Authors:  R Candau; D M Scolnick; P Darpino; C Y Ying; T D Halazonetis; S L Berger
Journal:  Oncogene       Date:  1997-08-14       Impact factor: 9.867

6.  Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain.

Authors:  W Gu; R G Roeder
Journal:  Cell       Date:  1997-08-22       Impact factor: 41.582

7.  Transactivation ability of p53 transcriptional activation domain is directly related to the binding affinity to TATA-binding protein.

Authors:  J Chang; D H Kim; S W Lee; K Y Choi; Y C Sung
Journal:  J Biol Chem       Date:  1995-10-20       Impact factor: 5.157

8.  Phosphorylation of p53 serine 15 increases interaction with CBP.

Authors:  P F Lambert; F Kashanchi; M F Radonovich; R Shiekhattar; J N Brady
Journal:  J Biol Chem       Date:  1998-12-04       Impact factor: 5.157

9.  Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein.

Authors:  J Lin; J Chen; B Elenbaas; A J Levine
Journal:  Genes Dev       Date:  1994-05-15       Impact factor: 11.361

10.  Phosphorylation of CREB at Ser-133 induces complex formation with CREB-binding protein via a direct mechanism.

Authors:  D Parker; K Ferreri; T Nakajima; V J LaMorte; R Evans; S C Koerber; C Hoeger; M R Montminy
Journal:  Mol Cell Biol       Date:  1996-02       Impact factor: 4.272

View more
  34 in total

1.  CCAAT/Enhancer-binding protein beta DNA binding is auto-inhibited by multiple elements that also mediate association with p300/CREB-binding protein (CBP).

Authors:  Sook Lee; Maria Miller; Jon D Shuman; Peter F Johnson
Journal:  J Biol Chem       Date:  2010-05-07       Impact factor: 5.157

2.  Aurora A mediates cross-talk between N- and C-terminal post-translational modifications of p53.

Authors:  Lorna Jane Warnock; Sally Anne Raines; Jo Milner
Journal:  Cancer Biol Ther       Date:  2011-12-15       Impact factor: 4.742

Review 3.  Posttranslational modification of p53: cooperative integrators of function.

Authors:  David W Meek; Carl W Anderson
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-10-28       Impact factor: 10.005

4.  Mechanism of Mediator recruitment by tandem Gcn4 activation domains and three Gal11 activator-binding domains.

Authors:  Eric Herbig; Linda Warfield; Lisa Fish; James Fishburn; Bruce A Knutson; Beth Moorefield; Derek Pacheco; Steven Hahn
Journal:  Mol Cell Biol       Date:  2010-03-22       Impact factor: 4.272

5.  Structure of the Taz2 domain of p300: insights into ligand binding.

Authors:  Maria Miller; Zbigniew Dauter; Scott Cherry; Joseph E Tropea; Alexander Wlodawer
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-11-17

6.  Mdm2 and MdmX as Regulators of Gene Expression.

Authors:  Lynn Biderman; James L Manley; Carol Prives
Journal:  Genes Cancer       Date:  2012-03

7.  Dual-site interactions of p53 protein transactivation domain with anti-apoptotic Bcl-2 family proteins reveal a highly convergent mechanism of divergent p53 pathways.

Authors:  Ji-Hyang Ha; Jae-Sun Shin; Mi-Kyung Yoon; Min-Sung Lee; Fahu He; Kwang-Hee Bae; Ho Sup Yoon; Chong-Kil Lee; Sung Goo Park; Yutaka Muto; Seung-Wook Chi
Journal:  J Biol Chem       Date:  2013-01-11       Impact factor: 5.157

8.  Characterization of the p300 Taz2-p53 TAD2 complex and comparison with the p300 Taz2-p53 TAD1 complex.

Authors:  Lisa M Miller Jenkins; Hanqiao Feng; Stewart R Durell; Harichandra D Tagad; Sharlyn J Mazur; Joseph E Tropea; Yawen Bai; Ettore Appella
Journal:  Biochemistry       Date:  2015-03-16       Impact factor: 3.162

Review 9.  p53 N-terminal phosphorylation: a defining layer of complex regulation.

Authors:  Lisa M Miller Jenkins; Stewart R Durell; Sharlyn J Mazur; Ettore Appella
Journal:  Carcinogenesis       Date:  2012-04-12       Impact factor: 4.944

10.  Structural insights into TAZ2 domain-mediated CBP/p300 recruitment by transactivation domain 1 of the lymphopoietic transcription factor E2A.

Authors:  Marina R Lochhead; Alexandra D Brown; Alyssa C Kirlin; Seth Chitayat; Kim Munro; Jane E Findlay; George S Baillie; David P LeBrun; David N Langelaan; Steven P Smith
Journal:  J Biol Chem       Date:  2020-02-25       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.